论文部分内容阅读
紫杉醇（Ｐａｃｌｕｔａｒｅｌ）是从紫杉的树皮中提取的一种抗癌新药，由于其化学结构新颖，作用机理独特，故紫杉醇的开发利用被誉为９０年代抗肿瘤药三大成就之一。该药对铂类药物耐药的卵巢癌疗效较好［１］；作为新型的广谱抗肿瘤药物，它既是妇科卵巢癌、乳腺癌和非小细
Paclutarel is an anti-cancer drug extracted from the bark of yew. Due to its novel chemical structure and unique mechanism of action, the development and utilization of paclitaxel is regarded as one of the three major achievements of anti-cancer drugs in the 1990s. The drug has good efficacy for platinum-resistant ovarian cancer [1]; as a novel broad-spectrum antitumor drug, it is both gynecological ovarian cancer, breast cancer and non-small fine